AdvisorShares Pure US Cannabis ETF MSOS
Set alert
3.94 USD -0.14 -3.43%
At close · Oct 30
3.95 +0.01 +0.25%
After hours · Oct 30, 7:48 PM ET
3.84 Day range 4.04
2.96 52-week range 7.25
- YTD
- -16.53%
- 1 year
- -8.37%
- Open
- 4.04
- Prev close
- 4.08
- Mkt cap
- 529.90M
- Vol
- 5.62M
- Avg vol
- 4.74M
- EPS
- 0.00
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 3.84
- High
- 4.04
- Forward P/E
- 0.00
- Beta
- 0.00
- Short ratio
- 0.00
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 5.35
- 200-d avg
- 7.29
Key statistics
- Market cap
- 0
- Enterprise value
- 0
- Trailing P/E
- 0.00
- Forward P/E
- 0.00
- PEG ratio
- 0.00
- Price / sales
- 0.00
- Price / book
- 0.00
- EPS (TTM)
- 0.00
- Beta
- 0.00
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Shares outstanding
- 0
- Short % of float
- 0.00%
- 50-day average
- 5.35
- 200-day average
- 7.29
About AdvisorShares Pure US Cannabis ETF
The fund is an actively managed ETF that seeks to achieve its investment objective by investing, under normal circumstances, at least 80% of its net assets (plus any borrowings for investment purposes) in securities of companies that derive at least 50% of their net revenue from the marijuana and hemp business in the United States and in derivatives that have economic characteristics similar to such securities. It will concentrate at least 25% of its investments in the pharmaceuticals, biotechnology & life sciences industry group within the health care sector. The fund is non-diversified.
News
- Curaleaf's Higher Aurora Bid Raises the Stakes in Cannabis Consolidation
- AdvisorShares Pure US Cannabis ETF (NYSEARCA:MSOS) Shares Gap Down – Here’s What Happened
- MSOS: Pause On Cannabis Rescheduling - And Why Trulieve Is A Sneaky Pick
- 'DEA Judge Pauses Marijuana Rescheduling Hearing As Opponents Highlight Government Report Detailing ‘Gaps’ In Federal Processes'- Marijuana Moment
- Tilray Jumps 6%, Canopy Growth Climbs 3%, Aurora Cannabis Gains 4%: Here's Why TLRY Is Still Down 47% YTD
- Virginia and Texas Are About to Become Cannabis Battlegrounds. Here's Which Stocks Are Positioned to Win.
- MSOS: Adult-Use Rescheduling The Next Catalyst For Cannabis Stocks
- The Easiest Way to Bet on US Cannabis Is This One ETF
- Trulieve Makes History As First US Cannabis Stock On NYSE
- 'White House Pushes Congress To Keep Hemp CBD Products Legal By Amending Broad Ban That's Set To Take Effect Later This Year' - Marijuana Moment
Your note
Sign in to keep a note on MSOS — it syncs with the Stock Master app.